SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Impact of site of occlusion in proximal splenic artery embolisation for blunt splenic trauma.

Boscà-Ramon, A; Ratnam, L; Cavenagh, T; Chun, J-Y; Morgan, R; Gonsalves, M; Das, R; Ameli-Renani, S; Pavlidis, V; Hawthorn, B; et al. Boscà-Ramon, A; Ratnam, L; Cavenagh, T; Chun, J-Y; Morgan, R; Gonsalves, M; Das, R; Ameli-Renani, S; Pavlidis, V; Hawthorn, B; Ntagiantas, N; Mailli, L (2022) Impact of site of occlusion in proximal splenic artery embolisation for blunt splenic trauma. CVIR Endovasc, 5 (1). p. 43. ISSN 2520-8934 https://doi.org/10.1186/s42155-022-00315-0
SGUL Authors: Arumugam Ratnam, Lakshmi

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

BACKGROUND: Proximal splenic artery embolisation (PSAE) can be performed in stable patients with Association for the Surgery of Trauma (AAST) grade III-V splenic injury. PSAE reduces splenic perfusion but maintains viability of the spleen and pancreas via the collateral circulation. The hypothesized ideal location is between the dorsal pancreatic artery (DPA) and great pancreatic artery (GPA). This study compares the outcomes resulting from PSAE embolisation in different locations along the splenic artery. MATERIALS AND METHODS: Retrospective review was performed of PSAE for blunt splenic trauma (2015-2020). Embolisation locations were divided into: Type I, proximal to DPA; Type II, DPA-GPA; Type III, distal to GPA. Fifty-eight patients underwent 59 PSAE: Type I (7); Type II (27); Type III (25). Data was collected on technical and clinical success, post-embolisation pancreatitis and splenic perfusion. Statistical significance was assessed using a chi-squared test. RESULTS: Technical success was achieved in 100% of cases. Clinical success was 100% for Type I/II embolisation and 88% for Type III: one patient underwent reintervention and two had splenectomies for ongoing instability. Clinical success was significantly higher in Type II embolisation compared to Type III (p = 0.02). No episodes of pancreatitis occurred post-embolisation. Where post-procedural imaging was obtained, splenic perfusion remained 100% in Type I and II embolisation and 94% in Type III. Splenic perfusion was significantly higher in the theorized ideal Type II group compared to Type I and III combined (p = 0.01). CONCLUSION: The results support the proposed optimal embolisation location as being between the DPA and GPA.

Item Type: Article
Additional Information: © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: CVIR Endovasc
ISSN: 2520-8934
Language: eng
Dates:
DateEvent
20 August 2022Published
29 July 2022Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 35986797
Web of Science ID: WOS:000842150900001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115043
Publisher's version: https://doi.org/10.1186/s42155-022-00315-0

Actions (login required)

Edit Item Edit Item